TRACY CANDACE DEGENSTEIN: Open Payments
NPI 1003895533 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,174 in 77 payments from 19 companies in 2025. Trend: 2023 $2,083 · 2024 $2,135 · 2025 $2,174
Food & beverage: $2,174
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $736 |
| Novo Nordisk Inc | 16 | $296 |
| Axsome Therapeutics, Inc. | 4 | $185 |
| ABBVIE INC. | 10 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $116 |
| Daiichi Sankyo Inc. | 2 | $109 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| Corcept Therapeutics | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $62 |
Products named: FARXIGA, Auvelity, Wegovy, BREZTRI, AIRSUPRA, CAPLYTA, INJECTAFER, REXULTI.
Industry payments across WA — which companies pay providers there.
